174 studies found for:    lupus | Open Studies
Show Display Options
Rank Status Study
21 Unknown  Cutaneous Lupus Erythematosus and Elidel
Conditions: Lupus Erythematosus, Cutaneous;   Lupus Erythematosus, Discoid
Intervention: Drug: Elidel (pimecrolimus)
22 Not yet recruiting RING - Rituximab for Lupus Nephritis With Remission as a Goal
Condition: Lupus Nephritis
Interventions: Drug: RTX  infusions;   Other: Standard of Care
23 Not yet recruiting A Pilot Study of CC-220 to Treat Systemic Lupus Erythematosus.
Condition: Systemic Lupus Erythematosus
Interventions: Drug: CC-220;   Drug: Placebo
24 Recruiting Umbilical Cord Derived Mesenchymal Stem Cells Transplantation for Active and Refractory Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention: Biological: human umbilical cord derived MSC transplantation for SLE
25 Recruiting Aerobic Exercise on Improving Sleep in Systemic Lupus Erythematosus.
Conditions: Systemic Lupus Erythematosus;   Sleep Disorders
Interventions: Procedure: Aerobic Exercise;   Other: Control Group
26 Unknown  Lupus Genetics Studies
Condition: Systemic Lupus Erythematosus
Intervention:
27 Recruiting Safety and Effectiveness of Belimumab in Systemic Lupus Erythematosus Registry
Condition: Systemic Lupus Erythematosus
Interventions: Biological: BENLYSTA;   Other: SLE treatment
28 Unknown  Cardiology Prevention in Systemic Lupus Erythematosus (SLE)
Condition: Systemic Lupus Erythematosus
Interventions: Other: Preventive Cardiology;   Other: Usual Care
29 Recruiting Low-dose UVA1 Radiation in Cutaneous Lupus Patients
Condition: Cutaneous Lupus Erythematosus
Intervention: Device: UVA1 radiation treatment
30 Recruiting Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Biological: Placebo plus standard therapy;   Biological: Belimumab 10 mg/kg plus standard therapy;   Drug: Standard therapy
31 Unknown  Effect of Mesenchymal Stem Cell Transplantation for Lupus Nephritis
Condition: Lupus Nephritis
Intervention: Biological: mesenchymal stem cell
32 Recruiting Clinical Trial Treatment in Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Drug: cyclosporine +mycophenolic acid+prednison;   Drug: Mycophenolic Acid + prednison
33 Recruiting Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Biological: BMS-188667;   Drug: Mycophenolate mofetil;   Drug: Prednisone;   Biological: Placebo matching with BMS-188667
34 Recruiting Prevalence and Clinical Severity of Cutaneous Lupus Erythematosus
Condition: Cutaneous Lupus Erythematosus
Intervention:
35 Not yet recruiting IL-26 and Systemic Lupus Erythematosus
Condition: Diagnosis of Lupus According to ACR criteriaAgreement for the Blood Sampling
Intervention:
36 Recruiting Weaning of Immunosuppression in Nephritis of Lupus
Condition: Nephritis of Lupus
Interventions: Drug: mycophenolate mofetil  or azathioprine;   Other: immunosuppressive treatment discontinuation
37 Not yet recruiting Trial of Rituximab and Mycophenolate Mofetil Without Oral Steroids for Lupus Nephritis
Condition: Systemic Lupus Erythematosus, Lupus Nephritis
Interventions: Drug: Oral prednisolone;   Drug: Rituximab;   Drug: Mycophenolate mofetil;   Drug: Methyl prednisolone
38 Unknown  The Safety and Efficacy of Etanercept (Enbrel®) for the Treatment of Discoid Lupus Erythematosus
Condition: Discoid Lupus Erythematosus (DLE)
Intervention: Drug: etanercept(Enbrel®)
39 Recruiting GENetic & Immunologic Abnomalies in Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus (SLE)
Intervention: Genetic: Blood sampling
40 Not yet recruiting Phase Ib Study of SC Milatuzumab in SLE
Conditions: Lupus Erythematosus, Cutaneous;   Lupus Erythematosus, Discoid;   Lupus Erythematosus, Systemic;   Lupus Vasculitis, Central Nervous System;   Lupus Nephritis
Intervention: Drug: milatuzumab

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years